XVI - Hemorrhage - Bleeding - Hematoma
Alveolar hemorrhage, diffuse (ANCA-positive/-related)
Last update 17/06/2026
(Fr: Hémorragie alvéolaire avec ANCA (divers types possibles). See also under III a (bland DAH) and XII: ANCA-related vasculitis.
XVI - Hemorrhage - Bleeding - Hematoma
Last update 17/06/2026
(Fr: Hémorragie alvéolaire avec ANCA (divers types possibles). See also under III a (bland DAH) and XII: ANCA-related vasculitis.
Frequency - Incidence
Incidence of cardiac adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for cardiac adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic